BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

327 filings reported holding BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 171,539,419 shares of 193,828,463 outstanding shares and own 89% of the company stock.
Largest 10 shareholders include Kohlberg Kravis Roberts & Co. L.P. (31,060,971 shares), VIKING GLOBAL INVESTORS LP (25,120,991 shares), VANGUARD GROUP INC (13,222,126 shares), BlackRock Inc. (10,466,935 shares), Aisling Capital Management LP (6,068,125 shares), STATE STREET CORP (5,392,862 shares), Laurion Capital Management LP (5,176,328 shares), Frazier Life Sciences Management, L.P. (3,415,604 shares), JANUS HENDERSON GROUP PLC (3,312,706 shares), and Cormorant Asset Management, LP (3,203,029 shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.